Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R)
Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. It has the potential for chronic obstructive pulmonary disease (COPD), asthama treatment. MW :145.5 KD
| Trivial name | MSTT 1041A |
| Catalog Number | A2443 |
| CAS# | 2173054-79-8 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/astegolimab-anti-il-1rl1-st2-il-33r.html |